A new manuscript from the IGNITE Pragmatic Trials Network has been published in JAMA Network Open, describing the primary results of the GUARDD-US study. GUARDD-US is a randomized controlled trial examining the impact of returning APOL1 genetic risk results to ...
2024 Precision Medicine Tri-Conference March 26-28 | San Diego, CA Join thousands of international thought leaders to discuss the latest research, technologies, innovation and business models in precision medicine and […]
The All of Us Research Program Thursday, March 28 | 9 a.m. ET | Online Speaker: Geoffrey Ginsburg, MD, PhD Dr. Geoffrey Ginsburg is the chief medical and scientific officer of […]
GMKB